Brief: Burning Rock Launches Prospective Pan-Cancer Multi-Omics Early Detection Study
19/05/2021 10:09
May 19 (Reuters) - Burning Rock Biotech Ltd BNR.O :
* BURNING ROCK ANNOUNCES THE LAUNCH OF CHINA’S FIRST
PROSPECTIVE
PAN-CANCER MULTI-OMICS EARLY DETECTION STUDY
* STUDY IS EXPECTED TO ENROLL 11,879 PARTICIPANTS ACROSS 22
CANCER
TYPES AS WELL AS HEALTHY CONTROLS
Source text for Eikon: ID:nGNX5yHX7
Further company coverage: BNR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Burning Rock Biotech
See all newsBurning Rock Biotech's Q2 revenue falls, net loss widens on central laboratory weakness
China's Burning Rock Biotech Q1 revenue falls on lower test volumes
China's Burning Rock Biotech Q4 net loss narrows as costs fall
Cancer diagnostics firm Burning Rock Biotech's Q3 revenue rises on pharma R&D growth
Brief: Burning Rock's Oncoguide™ Oncoscreen™ Plus CDX System Now Approved In Japan As A Companion Diagnostic For Capivasertib In Breast Cancer